Stock Alerts
With Vaxart you get Volatility–here’s why it’s so extreme
Yesterday shares of Vaxart (VXRT) were up 46.79%. Today they're down 16.13% as of noon in New York. And, of course the shares are down 55.38% since I bought them on July 22, 2020 at $14.79. Why so much, such extraordinary volatility? Some is because this is the kind...
Adding shares of Berkshire Hathaway (BRK/B) to my Jubak Picks Portfolio
Warren Buffet's Berkshire Hathaway (BRK-B) hit the headlines today on news that it had made a big buy in shares of Japanese trading companies. To me that looks like a typical Buffett value play on commodities and international trade at a time when the market in...
Adding Pfizer to my Dividend Portfolio today
You remember how in Part 3A of my Special Report: Meeting Your Retirement Challenge, I suggested that when temporary factors created an opportunity to buy the shares of a solid, predictable, cash flow generating company, with a yield of 4% you should jump at the...
Barrick Gold raises dividend 14%
Shares of Barrick Gold (GOLD) are up 11.10% today to $29.99 as of 1:30 p.m. New York time on Monday, August 17. The continued climb in Barrick Gold shares comes on the strength of an ongoing rally in gold prices and news that broke on Friday that Warren Buffett's...
My coronavirus vaccine pick Vaxart continues its recovery
Shares of Vaxart (VXRT) were up 21.77% today to $11.44 as of 3:15 p.m. New York time. You'll remember that Vaxart is my pick in my Volatility Portfolio for participating in the coronavirus vaccine race that plunged 47.6% from $16.97 on July 14 to to $8.90 a share on...
Ericsson is my 5G network pick
Ericsson (ERIC) has been piling up the contract wins for 5G networks. That's the future--which is why I'm recommending buying this ADR in my Jubak Picks Portfolio today. If you want to ride the transition to 5G telecommunications network, this is the best horse to...
Incyte beats on earnings, revenue–but drops on lack of improved guidance
Shares of biotech Incyte (INCY) were down 2.60% as of 1:30 p.m. Tuesday on earnings and revenue that stomped Wall Street projections. The company reported second quarter adjusted earnings of $1.24 a share versus Wall Street projections for 50 cents a share. Earnings...
Here’s my pick for getting in on the coronavirus vaccine race
In case you needed a reminder that there's a coronavirus vaccine race going on, today Pfizer (PFE) and its partner BioNTech (BNTX) announced that they had signed a $2 billion deal with the U.S. government to provide 100 million doses of its coronavirus vaccine...
Charles Schwab misses on revenue and earnings drop 21% over year–but long-term metrics stay on track
On Thursday, after the close of trading in New York, brokerage Charles Schwab (SCHW) reported net revenue of $2.4 billion for the second quarter, a 9% drop year over year and short of the $2.47 billion projected by Wall Street analysts. Non-GAAP adjusted earnings fell...
Jubak Picks member Xylem gains 8.97% on upgraded guidance ahead of earnings
Just a reminder today from Xylem (XYL) of why the company is one of the best investments in trends in the water market. The shares moved up 8.97% ahead of the release of second quarter earnings on July 30, 2020 to close at $73.38. Today, July 14, I'm raising my target...
So how much worse will things get for Wells Fargo? Continuing to hold my Put Options but maybe taking a little profit
On today's bad news from JPMorgan Chase (JPM), Citigroup (C), and, especially, Wells Fargo (WFC), the Wells Fargo Put Options (WFC201016P00025000) I hold in my Volatility Portfolio had gained 20.62% to $3.10 as of 2 p.m. New York time today. That still leaves this...Jim’s Stock Alerts
Download Jim’s eBook for Free
